Search alternatives:
significant estimates » significant time (Expand Search), significant rates (Expand Search)
significantly lower » significantly higher (Expand Search)
estimates decrease » estimates decreased (Expand Search), estimated decrease (Expand Search), estimated release (Expand Search)
lower decrease » linear decrease (Expand Search), larger decrease (Expand Search), teer decrease (Expand Search)
Showing 41 - 60 results of 18,624 for search '(( significant estimates decrease ) OR ( significantly lower decrease ))', query time: 1.25s Refine Results
  1. 41
    S6 Fig -

    S6 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 42
    CBP per cumulative indication for daratumumab and pembrolizumab per vial.

    CBP per cumulative indication for daratumumab and pembrolizumab per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 43
    Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation.

    Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 44
    Implementation of indication-based pricing (10<sup>th</sup> scenario) for daratumumab and pembrolizumab.

    Implementation of indication-based pricing (10<sup>th</sup> scenario) for daratumumab and pembrolizumab. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 45
    Scenario analysis for daratumumab using a cumulative cost-based price per year per vial.

    Scenario analysis for daratumumab using a cumulative cost-based price per year per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 46
    Input parameters for the base-case analysis.

    Input parameters for the base-case analysis. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 47
    S2 Fig -

    S2 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 48
    S1 Data -

    S1 Data - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 49
    Hand choice: Proportions of right-hand use.

    Hand choice: Proportions of right-hand use. by Aoife M. Fitzpatrick (13955365)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 50
    Synthesis and visualisation of prior brain imaging and stimulation results involving reaching.

    Synthesis and visualisation of prior brain imaging and stimulation results involving reaching. by Aoife M. Fitzpatrick (13955365)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 51
    Response times.

    Response times. by Aoife M. Fitzpatrick (13955365)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 52
    Hand choice.

    Hand choice. by Aoife M. Fitzpatrick (13955365)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 53
    Concentration of RebA and Steviol showed increased significantly, whereas stevioside showed significant decrease in all the transgenic lines.

    Concentration of RebA and Steviol showed increased significantly, whereas stevioside showed significant decrease in all the transgenic lines. by Nazima Nasrullah (6874496)

    Published 2023
    Save to List
    Saved in:
  14. 54
    Graphs showing reproduction of selected South American annual case (a) and death (b) data using 1000 parameter sets drawn from post-burn-in distribution obtained from 4 Markov chains.

    Graphs showing reproduction of selected South American annual case (a) and death (b) data using 1000 parameter sets drawn from post-burn-in distribution obtained from 4 Markov chai... by Keith Fraser (1868587)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 55
    Maps of median projected λ<sub><i>S</i></sub> (a) and <i>R</i><sub>0</sub> (b) across 1st-level sub-national administrative regions in selected African countries.

    Maps of median projected λ<sub><i>S</i></sub> (a) and <i>R</i><sub>0</sub> (b) across 1st-level sub-national administrative regions in selected African countries. by Keith Fraser (1868587)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 56
    Diagram of SEIRV model of yellow fever transmission in humans showing zoonotic transfer from the sylvatic non-human primate reservoir (mediated by the λ<sub><i>S</i></sub> parameter) and transmission from infectious humans (mediated by the <i>R</i><sub>0</sub> parameter).

    Diagram of SEIRV model of yellow fever transmission in humans showing zoonotic transfer from the sylvatic non-human primate reservoir (mediated by the λ<sub><i>S</i></sub> paramete... by Keith Fraser (1868587)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 57
    Fig 6 -

    Fig 6 - by Keith Fraser (1868587)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 58
    Maps of median projected λ<sub><i>S</i></sub> (a) and <i>R</i><sub>0</sub> (b) across 1st-level sub-national administrative regions in selected South American countries.

    Maps of median projected λ<sub><i>S</i></sub> (a) and <i>R</i><sub>0</sub> (b) across 1st-level sub-national administrative regions in selected South American countries. by Keith Fraser (1868587)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 59
    Table of parameters.

    Table of parameters. by Keith Fraser (1868587)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 60
    Fig 7 -

    Fig 7 - by Keith Fraser (1868587)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: